Fulcrum Therapeutics, Inc. (FULC)
12.99
+4.09
(+45.96%)
USD |
NASDAQ |
Dec 08, 16:00
12.52
-0.47
(-3.62%)
After-Hours: 07:31
Fulcrum Therapeutics Shareholders Equity (Quarterly): 198.37M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Agios Pharmaceuticals, Inc. | 1.284B |
| Biogen, Inc. | 18.21B |
| CorMedix, Inc. | 374.13M |
| Apellis Pharmaceuticals, Inc. | 401.17M |
| NovaBay Pharmaceuticals, Inc. | 1.634M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 214.86M |
| Total Liabilities (Quarterly) | 16.49M |
| Debt to Equity Ratio | 0.0353 |
| Current Ratio | 17.70 |
| Net Debt Paydown Yield | 0.11% |